Mindfulness-Based Education for Type 2 Diabetes
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems likely that you can continue your current diabetes treatment, but you should confirm with the trial organizers.
What data supports the effectiveness of the treatment Mindfulness-Based Diabetes Education for Type 2 Diabetes?
Research shows that mindfulness-based interventions, like Mindfulness-Based Stress Reduction (MBSR), can significantly reduce diabetes-related stress and improve self-management behaviors. Studies also found improvements in diabetes distress, self-efficacy, and A1C levels, indicating better blood sugar control.12345
Is mindfulness-based education safe for people with type 2 diabetes?
Mindfulness-based education, such as Mindfulness-Based Stress Reduction (MBSR) and Mindfulness-Based Cognitive Therapy (MBCT), has been studied in people with diabetes and is generally considered safe. Participants in these studies reported high satisfaction and no significant safety concerns were noted.12456
How does the treatment Mindfulness-Based Diabetes Education differ from other treatments for type 2 diabetes?
Mindfulness-Based Diabetes Education is unique because it focuses on reducing stress and improving mental health through mindfulness practices, which can enhance diabetes self-management and reduce diabetes-related distress. Unlike traditional treatments that primarily target blood sugar levels, this approach emphasizes mental well-being and self-awareness to support overall diabetes care.12789
What is the purpose of this trial?
Diabetes distress is common affecting over one-third of people with type 2 diabetes, negatively impacting self-management and outcomes, and disproportionately affecting low-income individuals. The proposed project will conduct a pilot randomized controlled trial comparing Mindfulness-Based Diabetes Education to standard Diabetes Self-Management Education in adults with type 2 diabetes and elevated diabetes distress who receive care within safety-net healthcare systems in order to assess feasibility and acceptability.
Research Team
Caroline A Presley, MD, MPH
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for adults with type 2 diabetes who are experiencing high levels of stress related to their condition. Participants must be 19 or older, have a hemoglobin A1c level of at least 7.5%, and show moderate to severe distress on the Diabetes Distress Scale. They should also be receiving care from specific healthcare systems and not have severe psychiatric conditions like bipolar disorder or schizophrenia.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Mindfulness-Based Diabetes Education or standard Diabetes Self-Management Education in 8 weekly group sessions followed by 2 bimonthly individual sessions
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments at baseline, 2 months, and 6 months
Treatment Details
Interventions
- Mindfulness-Based Diabetes Education
- Standard Diabetes Self-Management Education (DSME)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor